International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy

There have been many advances in our knowledge about different aspects of P2Y receptor signaling since the last review published by our International Union of Pharmacology subcommittee. More receptor subtypes have been cloned and characterized and most orphan receptors deorphanized, so that it is now possible to provide a basis for a future subdivision of P2Y receptor subtypes. More is known about the functional elements of the P2Y receptor molecules and the signaling pathways involved, including interactions with ion channels. There have been substantial developments in the design of selective agonists and antagonists to some of the P2Y receptor subtypes. There are new findings about the mechanisms underlying nucleotide release and ectoenzymatic nucleotide breakdown. Interactions between P2Y receptors and receptors to other signaling molecules have been explored as well as P2Y-mediated control of gene transcription. The distribution and roles of P2Y receptor subtypes in many different cell types are better understood and P2Y receptor-related compounds are being explored for therapeutic purposes. These and other advances are discussed in the present review.

[1]  R. Stone,et al.  A release mechanism for stored ATP in ocular ciliary epithelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Schultz,et al.  Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides. , 1989, Trends in pharmacological sciences.

[3]  P. Rotllán,et al.  Specific dinucleoside polyphosphate cleaving enzymes from chromaffin cells: a fluorimetric study. , 1995, Biochimica et biophysica acta.

[4]  H. Schaff,et al.  Bioassay of EDRF from internal mammary arteries: implications for early and late bypass graft patency. , 1992, The Annals of thoracic surgery.

[5]  D. A. Brown,et al.  Properties of single M‐type KCNQ2/KCNQ3 potassium channels expressed in mammalian cells , 2001, The Journal of physiology.

[6]  G. Burnstock,et al.  A novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates. , 1996, Molecular pharmacology.

[7]  P. Emson,et al.  Regional and cellular distribution of the P2Y1 purinergic receptor in the human brain: Striking neuronal localisation , 2000, The Journal of comparative neurology.

[8]  M. Ebisawa,et al.  Identification of a lysophosphatidylserine receptor on mast cells. , 2006, Biochemical and biophysical research communications.

[9]  D. Robertson,et al.  Purinergic receptors in auditory neurotransmission , 2003, Hearing Research.

[10]  J. Boeynaems,et al.  The fate of P2Y-related orphan receptors: GPR80/99 and GPR91 are receptors of dicarboxylic acids , 2004, Purinergic Signalling.

[11]  J. Boeynaems,et al.  Overview of the P2 receptors. , 2005, Seminars in thrombosis and hemostasis.

[12]  Kyungmi Yang,et al.  Tyrosine 740 Phosphorylation of Discoidin Domain Receptor 2 by Src Stimulates Intramolecular Autophosphorylation and Shc Signaling Complex Formation* , 2005, Journal of Biological Chemistry.

[13]  J. Dranoff,et al.  Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[14]  S. Kannan Neutrophil chemotaxis: potential role of chemokine receptors in extracellular nucleotide induced Mac-1 expression. , 2003, Medical hypotheses.

[15]  J. T. Turner,et al.  Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  William A. Catterall,et al.  Neuromodulation of Na+ channels: An unexpected form of cellular platicity , 2001, Nature Reviews Neuroscience.

[17]  J. Goding,et al.  Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. , 2003, Biochimica et biophysica acta.

[18]  H. Zimmermann BIOCHEMISTRY, LOCALIZATION AND FUNCTIONAL ROLES OF ECTO-NUCLEOTIDASES IN THE NERVOUS SYSTEM , 1996, Progress in Neurobiology.

[19]  S. Schurmans,et al.  Loss of nucleotide regulation of epithelial chloride transport in the jejunum of P2Y4-null mice. , 2003, Molecular pharmacology.

[20]  R. Boucher,et al.  Identification of an Ecto-nucleoside Diphosphokinase and Its Contribution to Interconversion of P2 Receptor Agonists* , 1997, The Journal of Biological Chemistry.

[21]  S. Lightman,et al.  Molecular cloning and functional characterization of a rat pituitary G protein-coupled adenosine triphosphate (ATP) receptor. , 1996, Endocrinology.

[22]  G. Cutting,et al.  CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP , 1995, Cell.

[23]  L. Parise,et al.  Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets. , 2003, Blood.

[24]  T. K. Harden,et al.  Agonist action of adenosine triphosphates at the human P2Y1 receptor. , 1998, Molecular pharmacology.

[25]  J. Pintor,et al.  Nucleotides and dinucleotides in ocular physiology: New possibilities of nucleotides as therapeutic agents in the eye , 2003 .

[26]  C. Galletti,et al.  Cortical mechanisms of visual space representation , 1993 .

[27]  U. Walter,et al.  Flow Cytometry Analysis of Intracellular VASP Phosphorylation for the Assessment of Activating and Inhibitory Signal Transduction Pathways in Human Platelets , 1999, Thrombosis and Haemostasis.

[28]  M. Birch,et al.  Identification and cloning of human P2U purinoceptor present in osteoclastoma, bone, and osteoblasts , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  E. Barnard,et al.  ATP Acts via P2Y1 Receptors to Stimulate Acetylcholinesterase and Acetylcholine Receptor Expression: Transduction and Transcription Control , 2003, The Journal of Neuroscience.

[30]  J. Boyer,et al.  Structure–activity relationships of dinucleotides: Potent and selective agonists of P2Y receptors , 2005, Purinergic Signalling.

[31]  G. Wilkinson,et al.  Differential heterologous and homologous desensitization of two receptors for ATP (P2y purinoceptors and nucleotide receptors) coexisting on endothelial cells. , 1994, Molecular pharmacology.

[32]  H. Schaff,et al.  Global myocardial ischemia and reperfusion impair endothelium-dependent relaxations to aggregating platelets in the canine coronary artery. A possible cause of vasospasm after cardiopulmonary bypass. , 1992, The Journal of thoracic and cardiovascular surgery.

[33]  J. Camden,et al.  P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome. , 2005, Archives of oral biology.

[34]  T. Saito,et al.  Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor. , 2001, Molecular pharmacology.

[35]  R. Kumari,et al.  ATP and UTP responses of cultured rat aortic smooth muscle cells revisited: dominance of P2Y2 receptors , 2003, British journal of pharmacology.

[36]  J. Neary,et al.  Induction of COX‐2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling , 2002, Journal of neurochemistry.

[37]  K. Jacobson,et al.  A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor. , 1997, Molecular pharmacology.

[38]  M. Freund,et al.  Differential Involvement of the P2Y1 and P2Y12 Receptors in Platelet Procoagulant Activity , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[39]  J. Neary,et al.  P2Y2 receptors activate neuroprotective mechanisms in astrocytic cells , 2004, Journal of neurochemistry.

[40]  S. Hill,et al.  G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. , 1998, Trends in pharmacological sciences.

[41]  P. Mannucci,et al.  Deficiency of (33P)2MeS-ADP Binding Sites on Platelets with Secretion Defect, Normal Granule Stores and Normal Thromboxane A2 Production , 1997, Thrombosis and Haemostasis.

[42]  B. Nürnberg,et al.  The human platelet ADP receptor activates Gi2 proteins. , 1995, The Biochemical journal.

[43]  J. Camden,et al.  P2Y2 Nucleotide Receptors Enhance α-Secretase-dependent Amyloid Precursor Protein Processing* , 2005, Journal of Biological Chemistry.

[44]  E. Hirsch,et al.  A Selective Role for Phosphatidylinositol 3,4,5-Trisphosphate in the Gi-dependent Activation of Platelet Rap1B* , 2003, The Journal of Biological Chemistry.

[45]  A. Shah,et al.  Targeting αvβ3 and α5β1 for gene delivery to proliferating VSMCs: synergistic effect of TGF-β1 , 2003 .

[46]  S. Strittmatter,et al.  P2Y1 purinergic receptors in sensory neurons: contribution to touch-induced impulse generation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Bourguignon,et al.  Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. , 2001, European journal of pharmacology.

[48]  R. Tarran,et al.  Compartmentalized autocrine signaling to cystic fibrosis transmembrane conductance regulator at the apical membrane of airway epithelial cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  G. Weisman,et al.  P2Y2 nucleotide receptor signaling in human monocytic cells: Activation, desensitization and coupling to mitogen‐activated protein kinases , 2001, Journal of cellular physiology.

[50]  P. Pacaud,et al.  Nucleotide receptor P2u partially mediates ATP‐induced cell cycle progression of aortic smooth muscle cells , 1996, Journal of cellular physiology.

[51]  S. Kunapuli,et al.  P2 receptor subtypes in the cardiovascular system. , 1998, The Biochemical journal.

[52]  R. Lefkowitz,et al.  Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. , 1997, The Journal of biological chemistry.

[53]  G. Schmalzing,et al.  Synthesis and Structure−Activity Relationships of Suramin-Derived P2Y11 Receptor Antagonists with Nanomolar Potency , 2005 .

[54]  G. Burnstock,et al.  The recently deorphanized GPR80 (GPR99) proposed to be the P2Y15 receptor is not a genuine P2Y receptor. , 2005, Trends in pharmacological sciences.

[55]  G. Dubyak,et al.  Endotoxin Activation of Macrophages Does Not Induce ATP Release and Autocrine Stimulation of P2 Nucleotide Receptors1 , 2000, The Journal of Immunology.

[56]  A. Lawrence,et al.  Immunoreactive localisation of P2Y1 receptors within the rat and human nodose ganglia and rat brainstem: comparison with [α33P]deoxyadenosine 5′-triphosphate autoradiography , 2002, Neuroscience.

[57]  M. Southey,et al.  Chromosomal localization of the human P2y6 purinoceptor gene and phylogenetic analysis of the P2y purinoceptor family. , 1997, Genomics.

[58]  K. Austen,et al.  Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[59]  G. L. Waldo,et al.  Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor. , 2004, Molecular pharmacology.

[60]  R. Nicholas,et al.  Differential coupling of the human P2Y11 receptor to phospholipase C and adenylyl cyclase , 2001, British journal of pharmacology.

[61]  J. Sanes,et al.  Development of the vertebrate neuromuscular junction. , 1999, Annual review of neuroscience.

[62]  K. Sano,et al.  Molecular cloning, expression, and localization of a brain-specific phosphodiesterase I/nucleotide pyrophosphatase (PD-I alpha) from rat brain. , 1994, The Journal of biological chemistry.

[63]  J. Bourguignon,et al.  A general approach toward the synthesis of C-nucleoside pyrazolo[1,5-a]-1,3,5-triazines and their 3',5'-bisphosphate C-nucleotide analogues as the first reported in vivo stable P2Y(1)-receptor antagonists. , 2002, The Journal of organic chemistry.

[64]  M. J. Robertson,et al.  ADP can induce aggregation of human platelets via both P2Y1 and P2T receptors , 2000, British journal of pharmacology.

[65]  P. Mannucci,et al.  Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. , 1992, Blood.

[66]  F. Cattabeni,et al.  The biphasic response of rat vesical smooth muscle to ATP , 1995, British journal of pharmacology.

[67]  B. Saltin,et al.  Erythrocyte and the Regulation of Human Skeletal Muscle Blood Flow and Oxygen Delivery: Role of Circulating ATP , 2002, Circulation research.

[68]  G. Guidotti,et al.  Purification and cloning of a soluble ATP-diphosphohydrolase (apyrase) from potato tubers (Solanum tuberosum). , 1996, Biochemical and biophysical research communications.

[69]  R. Grygorczyk,et al.  Cell swelling-induced ATP release and gadolinium-sensitive channels. , 2002, American journal of physiology. Cell physiology.

[70]  M. Freissmuth,et al.  Inhibition of adenylyl cyclase by neuronal P2Y receptors , 2002, British journal of pharmacology.

[71]  G. Burnstock,et al.  P2 purinergic receptors: modulation of cell function and therapeutic potential. , 2000, The Journal of pharmacology and experimental therapeutics.

[72]  M. Simon,et al.  G 13 is an essential mediator of platelet activation in hemostasis and thrombosis , 2022 .

[73]  T. K. Harden,et al.  Direct Demonstration of Mechanically Induced Release of Cellular UTP and Its Implication for Uridine Nucleotide Receptor Activation* , 1997, The Journal of Biological Chemistry.

[74]  I. Novak,et al.  Visualization of ATP Release in Pancreatic Acini in Response to Cholinergic Stimulus , 2001, The Journal of Biological Chemistry.

[75]  R. Boucher,et al.  Chloride secretory response to extracellular ATP in human normal and cystic fibrosis nasal epithelia. , 1992, The American journal of physiology.

[76]  Michel Bouvier,et al.  Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.

[77]  C. Gachet,et al.  ATP derivatives are antagonists of the P2Y1 receptor: similarities to the platelet ADP receptor. , 1998, Molecular pharmacology.

[78]  K. Jacobson,et al.  Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors. , 2003, Biochemical pharmacology.

[79]  C. Gachet,et al.  The platelet P2 receptors in thrombosis. , 2005, Seminars in thrombosis and hemostasis.

[80]  So Yeong Lee,et al.  P2Y receptors modulate ion channel function through interactions involving the C-terminal domain. , 2003, Molecular pharmacology.

[81]  J. Hanrahan,et al.  CFTR-independent ATP release from epithelial cells triggered by mechanical stimuli. , 1997, The American journal of physiology.

[82]  K. Honn,et al.  Overexpression of platelet-type 12-lipoxygenase promotes tumor cell survival by enhancing alpha(v)beta(3) and alpha(v)beta(5) integrin expression. , 2003, Cancer research.

[83]  A. Chulkin,et al.  2-Thioether-5'-O-(1-thiotriphosphate)-adenosine derivatives: new insulin secretagogues acting through P2Y-receptors. , 1999, The Israel Medical Association journal : IMAJ.

[84]  G. Dubyak,et al.  Methylene ATP analogs as modulators of extracellular ATP metabolism and accumulation , 2004, British journal of pharmacology.

[85]  M. Goldman,et al.  Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells. , 2005, Blood.

[86]  Diomedes E Logothetis,et al.  PIP2 Activates KCNQ Channels, and Its Hydrolysis Underlies Receptor-Mediated Inhibition of M Currents , 2003, Neuron.

[87]  M. Idzko,et al.  Characterization of the biological activities of uridine diphosphate in human dendritic cells: Influence on chemotaxis and CXCL8 release. , 2004, Journal of cellular physiology.

[88]  A. Dolphin,et al.  G Protein Modulation of Voltage-Gated Calcium Channels , 2003, Pharmacological Reviews.

[89]  Z. Madhun,et al.  P2-purigenic receptors regulate phospholipase C and adenylate cyclase activities in immortalized Schwann cells. , 1996, The Biochemical journal.

[90]  Kazuhide Inoue,et al.  Selective expression of Gi/o‐coupled ATP receptor P2Y12 in microglia in rat brain , 2003, Glia.

[91]  J. T. Turner,et al.  An Rgd Sequence in the P2y2 Receptor Interacts with αVβ3 Integrins and Is Required for Go-Mediated Signal Transduction , 2001, The Journal of cell biology.

[92]  B. Sperlágh,et al.  P2Y1 receptor activation inhibits NMDA receptor-channels in layer V pyramidal neurons of the rat prefrontal and parietal cortex , 2003, Neurochemistry International.

[93]  M. Sturek,et al.  Cloning , Upregulation , and Mitogenic Role of Porcine P 2 Y 2 Receptor in Coronary Artery Smooth Muscle Cells , 2004 .

[94]  P. Insel,et al.  Cloning, expression, signaling mechanisms, and membrane targeting of P2Y(11) receptors in Madin Darby canine kidney cells. , 2001, Molecular pharmacology.

[95]  B. Suh,et al.  Differential regulation of P2Y11 receptor‐mediated signalling to phospholipase C and adenylyl cyclase by protein kinase C in HL‐60 promyelocytes , 2000, British journal of pharmacology.

[96]  R. Haslam Interactions of the pharmacological receptors of blood platelets with adenylate cyclase. , 1973, Series haematologica.

[97]  G Burnstock,et al.  Is there a basis for distinguishing two types of P2-purinoceptor? , 1985, General pharmacology.

[98]  C. Verderio,et al.  Pathophysiological roles of P2 receptors in glial cells. , 2006, Novartis Foundation symposium.

[99]  P. Illés,et al.  Stimulation of P2 receptors in the ventral tegmental area enhances dopaminergic mechanisms in vivo , 2001, Neuropharmacology.

[100]  Sreenivas Devidas,et al.  Cystic Fibrosis Transmembrane Conductance Regulator–associated ATP Release Is Controlled by a Chloride Sensor , 1998, The Journal of cell biology.

[101]  J. Boeynaems,et al.  Rapid up‐regulation of P2Y messengers during granulocytic differentiation of HL‐60 cells , 2000, FEBS letters.

[102]  M. Kaghad,et al.  Role of P2Y1 purinoceptor in ADP‐induced platelet activation , 1998, FEBS letters.

[103]  P. Dagnelie,et al.  Growth inhibition of lung cancer cells by adenosine 5′‐triphosphate , 2003 .

[104]  J. Changeux,et al.  Acetylcholine receptor gene expression at the developing neuromuscular junction. , 1995, Physiological reviews.

[105]  K. Jacobson Synthesis, Biological Activity, and Molecular Modeling of Ribose-Modified Deoxyadenosine Bisphosphate Analogues as P2Y1 Receptor Ligands. , 2000 .

[106]  L. D. Howell,et al.  Activation of G551D CFTR channel with MPB-91: regulation by ATPase activity and phosphorylation. , 2001, American journal of physiology. Cell physiology.

[107]  D. A. Brown,et al.  Inhibition of potassium and calcium currents in neurones by molecularly-defined P2Y receptors. , 2000, Journal of the autonomic nervous system.

[108]  G. Weisman,et al.  P2Y receptors in the nervous system: molecular studies of a P2Y2 receptor subtype from NG108-15 neuroblastoma x glioma hybrid cells. , 1999, Progress in brain research.

[109]  D. Larhammar,et al.  Pharmacological characterization of ligand–receptor interactions at the zebrafish bradykinin receptor , 2005, British journal of pharmacology.

[110]  S. Kunapuli,et al.  Arg333 and Arg334 in the COOH terminus of the human P2Y1 receptor are crucial for Gq coupling. , 2005, American journal of physiology. Cell physiology.

[111]  P. Holton,et al.  The capillary dilator substances in dry powders of spinal roots; a possible role of adenosine triphosphate in chemical transmission from nerve endings , 1954, The Journal of physiology.

[112]  J. Herbert,et al.  Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. , 2005, Seminars in thrombosis and hemostasis.

[113]  S. Kunapuli,et al.  Molecular Basis for ADP-induced Platelet Activation , 1998, The Journal of Biological Chemistry.

[114]  T. K. Harden,et al.  Expression of a cloned P2Y purinergic receptor that couples to phospholipase C. , 1994, Molecular pharmacology.

[115]  W. Hatton,et al.  ClC‐3 chloride channel is upregulated by hypertrophy and inflammation in rat and canine pulmonary artery , 2005, British journal of pharmacology.

[116]  M. Mortrud,et al.  The G protein-coupled receptor repertoires of human and mouse , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[117]  Geoffrey Burnstock,et al.  Do some nerve cells release more than one transmitter? , 1976, Neuroscience.

[118]  J. Ware,et al.  Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[119]  J. Encinas,et al.  Identification and Characterization of a Cell-Surface Receptor, P2Y15, for AMP and Adenosine* , 2004, Journal of Biological Chemistry.

[120]  J. Boeynaems,et al.  Pharmacological characterization of the human P2Y11 receptor , 1999, British journal of pharmacology.

[121]  G Burnstock,et al.  Potential therapeutic targets in the rapidly expanding field of purinergic signalling. , 2002, Clinical medicine.

[122]  J. Nishimura,et al.  P2UPurinergic Activation Leads to the Cell Cycle Progression from the G1to the S and M Phases but Not from the G0to G1Phase in Vascular Smooth Muscle Cells in Primary Culture , 1996 .

[123]  L. van der Weyden,et al.  Pharmacological profile of a novel cyclic AMP‐linked P2 receptor on undifferentiated HL‐60 leukemia cells , 1998, British journal of pharmacology.

[124]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[125]  B. Nieswandt,et al.  Evidence for cross-talk between glycoprotein VI and Gi-coupled receptors during collagen-induced platelet aggregation. , 2001, Blood.

[126]  M. Spedding,et al.  Potentiation by 2,2′‐pyridylisatogen tosylate of ATP‐responses at a recombinant P2Y1 purinoceptor , 1996, British journal of pharmacology.

[127]  J. Boeynaems,et al.  P2Y receptors: New subtypes, new functions , 2003 .

[128]  Jilly F. Evans,et al.  International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors , 2003, Pharmacological Reviews.

[129]  Grace Y Sun,et al.  Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes , 2002 .

[130]  J. Chambers,et al.  A G Protein-coupled Receptor for UDP-glucose* , 2000, The Journal of Biological Chemistry.

[131]  J. Deitmer,et al.  Purinergic modulation of synaptic input to Purkinje neurons in rat cerebellar brain slices , 2004, The European journal of neuroscience.

[132]  S. E. James,et al.  Purinergic receptor expression in the regenerating epidermis in a rat model of normal and delayed wound healing , 2003, Experimental dermatology.

[133]  D. Julius,et al.  Expression cloning of an ATP receptor from mouse neuroblastoma cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[134]  G. Burnstock Introduction: ATP and Its Metabolites as Potent Extracellular Agents , 2003 .

[135]  J. Herbert,et al.  Gi‐dependent and ‐independent mechanisms downstream of the P2Y12 ADP‐receptor , 2004, Journal of thrombosis and haemostasis : JTH.

[136]  A. Conigrave,et al.  Extracellular ATP triggers cyclic AMP-dependent differentiation of HL-60 cells. , 1997, Biochemical and biophysical research communications.

[137]  G. Milligan,et al.  Multiple pertussis toxin‐sensitive G‐proteins can couple receptors to GIRK channels in rat sympathetic neurons when expressed heterologously, but only native Gi‐proteins do so in situ , 2001, The European journal of neuroscience.

[138]  J. Boeynaems,et al.  Nucleotide receptor P2Y13 , 2006 .

[139]  S. Kirischuk,et al.  Activation of P2‐purinoreceptors triggered Ca2+ release from InsP3‐sensitive internal stores in mammalian oligodendrocytes. , 1995, The Journal of physiology.

[140]  Seiko F. Okada,et al.  Voltage-dependent Anion Channel-1 (VDAC-1) Contributes to ATP Release and Cell Volume Regulation in Murine Cells , 2004, The Journal of general physiology.

[141]  G. Fischbach,et al.  ARIA: a neuromuscular junction neuregulin. , 1997, Annual review of neuroscience.

[142]  H. Schaller,et al.  An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors. , 2001, Journal of molecular biology.

[143]  G Burnstock,et al.  Evidence That Release of Adenosine Triphosphate From Endothelial Cells During Increased Shear Stress Is Vesicular , 2001, Journal of cardiovascular pharmacology.

[144]  D. C. Marcus,et al.  Immunolocalization of P2Y4 and P2Y2 Purinergic Receptors in Strial Marginal Cells and Vestibular Dark Cells , 2002, The Journal of Membrane Biology.

[145]  J. Dickenson,et al.  Role of G-protein beta gamma subunits in the augmentation of P2Y2 (P2U)receptor-stimulated responses by neuropeptide Y Y1 Gi/o-coupled receptors. , 1997, The Biochemical journal.

[146]  A. Conigrave,et al.  P2Y(11) receptor expression by human lymphocytes: evidence for two cAMP-linked purinoceptors. , 2001, European journal of pharmacology.

[147]  G. Burnstock,et al.  Molecular cloning and characterization of rat P2Y4 nucleotide receptor , 1998, British journal of pharmacology.

[148]  J. T. Turner,et al.  PPADS and suramin as antagonists at cloned P2Y‐ and P2U‐purinoceptors , 1996, British journal of pharmacology.

[149]  W. Sadee,et al.  Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling. , 1993, The Journal of biological chemistry.

[150]  J. Galzi,et al.  Differential Regulation and Relocalization of the Platelet P2Y Receptors after Activation: A Way to Avoid Loss of Hemostatic Properties? , 2005, Molecular Pharmacology.

[151]  P. Light,et al.  Experiments to Test the Role of Phosphatidylinositol 4,5-Bisphosphate in Neurotransmitter-Induced M-Channel Closure in Bullfrog Sympathetic Neurons , 2003, The Journal of Neuroscience.

[152]  E. Barnard,et al.  Coupling of the nucleotide P2Y4 receptor to neuronal ion channels , 2003, British journal of pharmacology.

[153]  H Zimmermann,et al.  5'-Nucleotidase: molecular structure and functional aspects. , 1992, The Biochemical journal.

[154]  K. Jacobson,et al.  2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists. , 2003, Journal of medicinal chemistry.

[155]  P. Insel,et al.  An arginine/glutamine difference at the juxtaposition of transmembrane domain 6 and the third extracellular loop contributes to the markedly different nucleotide selectivities of human and canine P2Y11 receptors. , 2001, Molecular pharmacology.

[156]  K. Jacobson,et al.  Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors. , 2002, Journal of medicinal chemistry.

[157]  K. Jacobson,et al.  Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors. , 2004, Biochemical pharmacology.

[158]  J. Boeynaems,et al.  Cotranscription and Intergenic Splicing of HumanP2Y 11 and SSF1 Genes* , 2001, The Journal of Biological Chemistry.

[159]  D. Daret,et al.  Overexpression of P2Y2 purinoceptor in intimal lesions of the rat aorta. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[160]  J. Pfeilschifter,et al.  Extracellular nucleotides activate the p38‐stress‐activated protein kinase cascade in glomerular mesangial cells , 2000, British journal of pharmacology.

[161]  A. Farret,et al.  The P2Y1 receptor is involved in the maintenance of glucose homeostasis and in insulin secretion in mice , 2005, Purinergic Signalling.

[162]  2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: Enhanced potency as P2Y1 receptor antagonists , 2003 .

[163]  J. Axelrod,et al.  A transduction pathway associated with receptors coupled to the inhibitory guanine nucleotide binding protein Gi that amplifies ATP-mediated arachidonic acid release. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[164]  F. Monsma,et al.  Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. , 2001, The Journal of clinical investigation.

[165]  M. Cattaneo The P2 Receptors and Congenital Platelet Function Defects , 2005, Seminars in thrombosis and hemostasis.

[166]  M. Goldman,et al.  Extracellular adenine nucleotides modulate cytokine production by human monocyte‐derived dendritic cells: dual effect on IL‐12 and stimulation of IL‐10 , 2002, European journal of immunology.

[167]  A. Bailey,et al.  Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy. , 1999, Journal of medicinal chemistry.

[168]  R. Lefkowitz,et al.  Gβγ Subunits Mediate Src-dependent Phosphorylation of the Epidermal Growth Factor Receptor , 1997, The Journal of Biological Chemistry.

[169]  M. Knowles,et al.  Effect of uridine 5'-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis. , 1996, American journal of respiratory and critical care medicine.

[170]  R. Nicholas,et al.  Agonist Versus Antagonist Action of ATP at the P2Y4 Receptor Is Determined by the Second Extracellular Loop* , 2004, Journal of Biological Chemistry.

[171]  W. Watt,et al.  Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. , 1996, Molecular Pharmacology.

[172]  Y. Takuwa,et al.  Molecular Cloning and Functional Analysis of a Novel P2 Nucleotide Receptor (*) , 1995, The Journal of Biological Chemistry.

[173]  G. Burnstock,et al.  Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. , 2003, Trends in pharmacological sciences.

[174]  Catherine Vial,et al.  A Role of the Fast ATP-gated P2X1 Cation Channel in Thrombosis of Small Arteries In Vivo , 2003, The Journal of experimental medicine.

[175]  Mark S. Shapiro,et al.  Why Biophysicists Make Models , 2004, The Journal of general physiology.

[176]  B. Sperlágh,et al.  Neuronal synthesis, storage and release of ATP , 1996 .

[177]  Lan Bao,et al.  Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[178]  J. Cazenave,et al.  The P2Y1 receptor, necessary but not sufficient to support full ADP‐induced platelet aggregation, is not the target of the drug clopidogrel , 1998, British journal of haematology.

[179]  E. M. Silinsky,et al.  Synchronous release of ATP and neurotransmitter within milliseconds of a motor nerve impulse in the frog. , 1996, The Journal of physiology.

[180]  P. Zamecnik,et al.  Analogues of diadenosine 5',5'''-P1,P4-tetraphosphate (Ap4A) as potential anti-platelet-aggregation agents. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[181]  P. Emson,et al.  GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function. , 2003, Brain research. Molecular brain research.

[182]  M. Sturek,et al.  Cloning, Up-Regulation, and Mitogenic Role of Porcine P2Y2 Receptor in Coronary Artery Smooth Muscle Cells , 2004, Molecular Pharmacology.

[183]  J. T. Turner,et al.  Functional P2Y2 Nucleotide Receptors Mediate Uridine 5′-Triphosphate–Induced Intimal Hyperplasia in Collared Rabbit Carotid Arteries , 2002, Circulation.

[184]  G. Fischbach,et al.  Neuregulin and ErbB receptor signaling pathways in the nervous system , 2001, Current Opinion in Neurobiology.

[185]  S. Nielsen,et al.  P2Y6 receptor mediates colonic NaCl secretion via differential activation of cAMP-mediated transport. , 2003, The Journal of clinical investigation.

[186]  成田 正明 Molecular cloning, expression, and localization of a brain-specific phosphodiesterase I/nucleotide pyrophosphatase (PD-Iα) from rat brain , 1994 .

[187]  M. Knowles,et al.  Basal Nucleotide Levels, Release, and Metabolism in Normal and Cystic Fibrosis Airways , 2000, Molecular medicine.

[188]  T. K. Harden,et al.  The stable pyrimidines UDPβS and UTPγS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery , 2000 .

[189]  K. Jacobson,et al.  2,2'-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding. , 2004, Biochemical pharmacology.

[190]  I. Davis,et al.  ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling. , 2003, Blood.

[191]  R. Brambilla,et al.  Modulation of Cyclooxygenase‐2 and Brain Reactive Astrogliosis by Purinergic P2 Receptors , 2001, Annals of the New York Academy of Sciences.

[192]  G. Burnstock,et al.  Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells , 1996, Trends in Neurosciences.

[193]  M. Matteoli,et al.  Storage and Release of ATP from Astrocytes in Culture* , 2003, The Journal of Biological Chemistry.

[194]  T. K. Harden,et al.  Lack of nucleotide-promoted second messenger signaling responses in 1321N1 cells expressing the proposed P2Y receptor, p2y7. , 1997, Biochemical and biophysical research communications.

[195]  E. Barnard,et al.  Adenosine Nucleotides Acting at the Human P2Y1Receptor Stimulate Mitogen-activated Protein Kinases and Induce Apoptosis* , 2001, The Journal of Biological Chemistry.

[196]  K. Austen,et al.  Cysteinyl Leukotrienes and Uridine Diphosphate Induce Cytokine Generation by Human Mast Cells Through an Interleukin 4–regulated Pathway that Is Inhibited by Leukotriene Receptor Antagonists , 2002, The Journal of experimental medicine.

[197]  H. Zimmermann Extracellular metabolism of ATP and other nucleotides , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[198]  R. Sprague,et al.  Impaired Release of ATP from Red Blood Cells of Humans with Primary Pulmonary Hypertension , 2001, Experimental biology and medicine.

[199]  L. Pardo,et al.  A conserved Asn in TM7 of the thyrotropin receptor is a common requirement for activation by both mutations and its natural agonist , 2002, FEBS letters.

[200]  C. Matute,et al.  Immunohistochemical localization of the P2Y(1) purinergic receptor in neurons and glial cells of the central nervous system. , 2000, Brain research. Molecular brain research.

[201]  K. Jacobson,et al.  Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y11-like receptors. , 2005, Journal of molecular and cellular cardiology.

[202]  G. Burnstock,et al.  Cardiovascular Biology of Purines , 1998, Developments in Cardiovascular Medicine.

[203]  P. Insel,et al.  Cellular Release of and Response to ATP as Key Determinants of the Set-Point of Signal Transduction Pathways* , 2000, The Journal of Biological Chemistry.

[204]  Marc Parmentier,et al.  Cloning of a Human Purinergic P2Y Receptor Coupled to Phospholipase C and Adenylyl Cyclase* , 1997, The Journal of Biological Chemistry.

[205]  T. Schöneberg,et al.  The Structural Evolution of a P2Y-like G-protein-coupled Receptor* , 2003, Journal of Biological Chemistry.

[206]  F. Cattabeni,et al.  A novel gliotic P2 receptor mediating cyclooxygenase-2 induction in rat and human astrocytes. , 2000, Journal of the autonomic nervous system.

[207]  J. Luthardt,et al.  Interaction between P2Y and NMDA receptors in layer V pyramidal neurons of the rat prefrontal cortex , 2002, Neuropharmacology.

[208]  S. M. Sims,et al.  P2 purinergic receptors on osteoblasts and osteoclasts: Potential targets for drug development , 2000 .

[209]  J. Dickenson,et al.  Synergy between the inositol phosphate responses to transfected human adenosine A1‐receptors and constitutive P2‐purinoceptors in CHO‐K1 cells , 1995, British journal of pharmacology.

[210]  H. Nakata,et al.  Heteromeric association creates a P2Y-like adenosine receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[211]  A. Wetter,et al.  Molecular pharmacology of P2Y-receptors , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[212]  E. Barnard,et al.  Characterization and Channel Coupling of the P2Y12Nucleotide Receptor of Brain Capillary Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[213]  G. Weisman,et al.  The P2Y2 Nucleotide Receptor Mediates UTP-induced Vascular Cell Adhesion Molecule-1 Expression in Coronary Artery Endothelial Cells* , 2003, Journal of Biological Chemistry.

[214]  J. Camden,et al.  Src Homology 3 Binding Sites in the P2Y2 Nucleotide Receptor Interact with Src and Regulate Activities of Src, Proline-rich Tyrosine Kinase 2, and Growth Factor Receptors* , 2004, Journal of Biological Chemistry.

[215]  J. Bourguignon,et al.  Synthesis and biological activity of 2-alkylated deoxyadenosine bisphosphate derivatives as P2Y1 receptor antagonists , 2004 .

[216]  Kenneth A. Jacobson,et al.  The Role of Amino Acids in Extracellular Loops of the Human P2Y1 Receptor in Surface Expression and Activation Processes* , 1999, The Journal of Biological Chemistry.

[217]  B. King Molecular Biology of P2X Purinoceptors , 1998 .

[218]  J. Leipziger Control of epithelial transport via luminal P2 receptors. , 2003, American journal of physiology. Renal physiology.

[219]  G. Burnstock Introduction: P2 receptors. , 2004, Current topics in medicinal chemistry.

[220]  E. Schwiebert,et al.  Bioluminescence detection of ATP release mechanisms in epithelia. , 1998, American journal of physiology. Cell physiology.

[221]  V. Cressman,et al.  Effect of Loss of P2Y2 Receptor Gene Expression on Nucleotide Regulation of Murine Epithelial Cl−Transport* , 1999, The Journal of Biological Chemistry.

[222]  Á. Simonyi,et al.  Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[223]  G. Burnstock A basis for distinguishing two types of purinergic receptor , 1978 .

[224]  J. Pintor,et al.  Adenosine Tetraphosphate, Ap4, a Physiological Regulator of Intraocular Pressure in Normotensive Rabbit Eyes , 2004, Journal of Pharmacology and Experimental Therapeutics.

[225]  E. Barnard,et al.  Molecular Cloning and Characterization of the Rat P2Y4 Receptor , 1998, Journal of neurochemistry.

[226]  A. Wilks,et al.  Murine plasma cell membrane antigen PC-1: molecular cloning of cDNA and analysis of expression. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[227]  M. Slater,et al.  Purinergic receptor expression in the apical plasma membrane of rat uterine epithelial cells during implantation. , 2002, Cell calcium.

[228]  M. Parmentier,et al.  Cloning and tissue distribution of the human P2Y1 receptor. , 1996, Biochemical and biophysical research communications.

[229]  Activity of novel adenine nucleotide derivatives as agonists and antagonists at recombinant rat P2X receptors , 2000, Drug development research.

[230]  P. Conley,et al.  Impaired activation of murine platelets lacking Gαi2 , 2001 .

[231]  S. Jalkanen,et al.  The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells. , 2002, The Biochemical journal.

[232]  L. Liotta,et al.  Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.

[233]  D. Erlinge,et al.  MAPKK-dependent growth factor-induced upregulation of P2Y2 receptors in vascular smooth muscle cells. , 1999, Biochemical and biophysical research communications.

[234]  A. Tobin,et al.  G-protein-coupled receptor regulation of P2X1 receptors does not involve direct channel phosphorylation. , 2004, The Biochemical journal.

[235]  B. Nieswandt,et al.  The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanism. , 2001, FEBS letters.

[236]  G. Mills,et al.  Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.

[237]  M. Knowles,et al.  Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate +/- amiloride in normal human adults. , 1996, American journal of respiratory and critical care medicine.

[238]  D. Jagger,et al.  Purinergic Regulation of Sound Transduction and Auditory Neurotransmission , 2002, Audiology and Neurotology.

[239]  K. Jacobson,et al.  Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists. , 2002, Journal of medicinal chemistry.

[240]  K. Gunderson,et al.  Failure of the Cystic Fibrosis Transmembrane Conductance Regulator to Conduct ATP , 1996, Science.

[241]  Martyn P Mahaut-Smith,et al.  Emerging roles for P2X1 receptors in platelet activation , 2004, Platelets.

[242]  J. Clancy,et al.  Cystic Fibrosis Transmembrane Conductance Regulator Facilitates ATP Release by Stimulating a Separate ATP Release Channel for Autocrine Control of Cell Volume Regulation* , 2001, The Journal of Biological Chemistry.

[243]  B. Yerxa Therapeutic use of nucleotides in respiratory and ophthalmic diseases , 2001 .

[244]  J. T. Turner,et al.  Salivary Gland Nucleotide Receptors: Changes in Expression and Activity Related to Development and Tissue Damage a, , 1998, Annals of the New York Academy of Sciences.

[245]  J. Neary,et al.  P2Y receptors in brain astroglial cells: Identification of a gliotic P2Y receptor coupled to activation of a calcium‐independent ras/ERK1/2 pathway , 2003 .

[246]  P. Emson,et al.  Expression pattern of human P2Y receptor subtypes: a quantitative reverse transcription-polymerase chain reaction study. , 2001, Biochimica et biophysica acta.

[247]  David Julius,et al.  Identification of the platelet ADP receptor targeted by antithrombotic drugs , 2001, Nature.

[248]  R. North Molecular physiology of P2X receptors. , 2002, Physiological reviews.

[249]  J. T. Turner,et al.  Structural Basis of Agonist-induced Desensitization and Sequestration of the P2Y2 Nucleotide Receptor , 1998, The Journal of Biological Chemistry.

[250]  D. Erlinge,et al.  ADP Receptor P2Y12 Is Expressed in Vascular Smooth Muscle Cells and Stimulates Contraction in Human Blood Vessels , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[251]  C. Toth,et al.  Effect of INS37217, a P2Y(2) receptor agonist, on experimental retinal detachment and electroretinogram in adult rabbits. , 2002, Investigative ophthalmology & visual science.

[252]  Á. Simonyi,et al.  Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes. , 2002, Journal of neurochemistry.

[253]  P. Illés,et al.  Adenine nucleotides inhibit recombinant N‐type calcium channels via G protein‐coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor‐type , 2004, British journal of pharmacology.

[254]  C. Müller,et al.  Flavonoids — novel lead compounds for the development of P2Y2 receptor antagonists , 2003 .

[255]  R. Boucher,et al.  Pharmacology of INS37217 [P1-(Uridine 5′)-P4- (2′-deoxycytidine 5′)tetraphosphate, Tetrasodium Salt], a Next-Generation P2Y2 Receptor Agonist for the Treatment of Cystic Fibrosis , 2002, Journal of Pharmacology and Experimental Therapeutics.

[256]  G. Reiser,et al.  Adenosine 5'-O-(1-boranotriphosphate) derivatives as novel P2Y(1) receptor agonists. , 2002, Journal of medicinal chemistry.

[257]  D. Erlinge,et al.  Potent P2Y6 receptor mediated contractions in human cerebral arteries , 2003, BMC pharmacology.

[258]  Andrew D. Powell,et al.  Identification of the P2Y(12) receptor in nucleotide inhibition of exocytosis from bovine chromaffin cells. , 2004, Molecular pharmacology.

[259]  L. A. Simeoni,et al.  Evidence for Multidrug Resistance-1 P-Glycoprotein-dependent Regulation of Cellular ATP Permeability , 2001, The Journal of Membrane Biology.

[260]  G. Burnstock,et al.  Involvement of purinergic signaling in cardiovascular diseases. , 2003, Drug news & perspectives.

[261]  Nina L. Siow,et al.  P2Y2 Receptor Activation Regulates the Expression of Acetylcholinesterase and Acetylcholine Receptor Genes at Vertebrate Neuromuscular Junctions , 2004, Molecular Pharmacology.

[262]  T Kendall Harden,et al.  Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. , 2003, Molecular pharmacology.

[263]  G. Weisman,et al.  Differential agonist-induced desensitization of P2Y2 nucleotide receptors by ATP and UTP , 2000, Molecular and Cellular Biochemistry.

[264]  J. T. Turner,et al.  Cloning, Expression, and Chromosomal Localization of the Human Uridine Nucleotide Receptor Gene (*) , 1995, The Journal of Biological Chemistry.

[265]  J. Nishimura,et al.  P2U purinergic activation leads to the cell cycle progression from the G1 to the S and M phases but not from the G0 to G1 phase in vascular smooth muscle cells in primary culture. , 1996, Biochemical and biophysical research communications.

[266]  J. Sévigny,et al.  Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8. , 2004, Biochemistry.

[267]  G. Dubyak,et al.  Down-regulation of P2U-purinergic nucleotide receptor messenger RNA expression during in vitro differentiation of human myeloid leukocytes by phorbol esters or inflammatory activators. , 1997, Molecular pharmacology.

[268]  R. Duman,et al.  The isolation and characterization of a novel G protein-coupled receptor regulated by immunologic challenge , 1997, Brain Research.

[269]  B. Kishore,et al.  P2Y2 receptor-stimulated release of prostaglandin E2 by rat inner medullary collecting duct preparations. , 2003, American journal of physiology. Renal physiology.

[270]  J. Goding,et al.  Biochemical and molecular identification of distinct forms of alkaline phosphodiesterase I expressed on the apical and basolateral plasma membrane surfaces of rat hepatocytes , 1997, Hepatology.

[271]  L. Brass,et al.  Activation of Rap1B by Gi Family Members in Platelets* , 2002, The Journal of Biological Chemistry.

[272]  S. Koizumi,et al.  Dynamic inhibition of excitatory synaptic transmission by astrocyte-derived ATP in hippocampal cultures , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[273]  A. Szent-Györgyi,et al.  The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart 1 , 1929, The Journal of physiology.

[274]  H. Schlüter,et al.  Structure‐activity relationships of diadenosine polyphosphates (ApnAs), adenosine polyphospho guanosines (ApnGs) and guanosine polyphospho guanosines (GpnGs) at P2 receptors in the rat mesenteric arterial bed , 2001, British journal of pharmacology.

[275]  T. K. Harden,et al.  Evidence that the p2y3 receptor is the avian homologue of the mammalian P2Y6 receptor. , 1998, Molecular pharmacology.

[276]  Kyong-Tai Kim,et al.  Protein kinase C regulates the activity and stability of serotonin N‐acetyltransferase , 2004, Journal of neurochemistry.

[277]  J. Herbert,et al.  P2y(12), a new platelet ADP receptor, target of clopidogrel. , 2001, Biochemical and biophysical research communications.

[278]  J. Schlessinger,et al.  Src and Pyk2 Mediate G-protein-coupled Receptor Activation of Epidermal Growth Factor Receptor (EGFR) but Are Not Required for Coupling to the Mitogen-activated Protein (MAP) Kinase Signaling Cascade* , 2001, The Journal of Biological Chemistry.

[279]  A. Townsend-Nicholson,et al.  Recombinant P2Y receptors: the UCL experience. , 2000, Journal of the autonomic nervous system.

[280]  D. Erlinge,et al.  The stable pyrimidines UDPbetaS and UTPgammaS discriminate between contractile cerebrovascular P2 receptors. , 2003, European journal of pharmacology.

[281]  J. Boeynaems,et al.  Slow desensitization of the human P2Y6 receptor. , 1997, European journal of pharmacology.

[282]  G. Burnstock,et al.  P2Y Receptors Present in the Native and Isolated Rat Glomerulus , 2004, Nephron Physiology.

[283]  Melvin I. Simon,et al.  Muscarinic Inhibition of Calcium Current and M Current in Gαq-Deficient Mice , 2000, The Journal of Neuroscience.

[284]  T. K. Harden,et al.  Quantitation of extracellular UTP using a sensitive enzymatic assay , 1999, British journal of pharmacology.

[285]  A. Glatz,et al.  P2Y receptor subtypes differentially couple to inwardly‐rectifying potassium channels , 1998, FEBS letters.

[286]  P. Conley,et al.  Novel tricyclic benzothiazolo[2,3-c]thiadiazine antagonists of the platelet ADP receptor (P2Y(12)). , 2001, Bioorganic & medicinal chemistry letters.

[287]  B. Levitt,et al.  High-pressure liquid chromatographic-fluorometric detection of adenosine and adenine nucleotides: application to endogenous content and electrically induced release of adenyl purines in guinea pig vas deferens. , 1984, Analytical biochemistry.

[288]  K. Jacobson,et al.  2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist. , 2002, British journal of pharmacology.

[289]  P. D. Bell,et al.  Macula densa cell signaling involves ATP release through a maxi anion channel , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[290]  T. K. Harden,et al.  Purification and functional reconstitution of the human P2Y12 receptor. , 2003, Molecular pharmacology.

[291]  H. Nakata,et al.  Agonist‐promoted heteromeric oligomerization between adenosine A1 and P2Y1 receptors in living cells , 2002, FEBS letters.

[292]  P. Seth,et al.  p27Kip1 is an inducer of intestinal epithelial cell differentiation , 2000 .

[293]  Kenneth A Jacobson,et al.  Molecular modeling as a tool to investigate molecular recognition in P2Y receptors. , 2002, Current pharmaceutical design.

[294]  G. Burnstock,et al.  Molecular cloning and characterization of rat P2Y(4) nucleotide receptor , 1998 .

[295]  K. Austen,et al.  Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[296]  M. Spedding,et al.  IDENTIFICATION OF SEPARATE RECEPTORS FOR ADENOSINE AND ADENOSINE 5′‐TRIPHOSPHATE IN CAUSING RELAXATIONS OF THE ISOLATED TAENIA OF THE GUINEA‐PIG CAECUM , 1976, British journal of pharmacology.

[297]  S. Buvinic,et al.  P2Y1 and P2Y2 receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed , 2002, British journal of pharmacology.

[298]  J. Boeynaems,et al.  The role of epithelial P2Y2 and P2Y4 receptors in the regulation of intestinal chloride secretion , 2005, British journal of pharmacology.

[299]  C. Martini,et al.  Cloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y(13) receptor. , 2004, Biochemical pharmacology.

[300]  C. Gachet,et al.  Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases , 2005, Journal of thrombosis and haemostasis : JTH.

[301]  Seiko F. Okada,et al.  Nucleotide Release Provides a Mechanism for Airway Surface Liquid Homeostasis* , 2004, Journal of Biological Chemistry.

[302]  P. Conley,et al.  P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. , 2003, The Journal of clinical investigation.

[303]  S. C. Wolff,et al.  The Apical Targeting Signal of the P2Y2 Receptor Is Located in Its First Extracellular Loop* , 2005, Journal of Biological Chemistry.

[304]  A. Dahlström,et al.  Axonal transport and targeting of the t-SNAREs SNAP-25 and syntaxin 1 in the peripheral nervous system. , 1996, European journal of cell biology.

[305]  K. Jacobson,et al.  Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor. , 2005, Biochemical pharmacology.

[306]  M. Welsh,et al.  A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[307]  G. Burnstock,et al.  Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate. , 1993, Journal of medicinal chemistry.

[308]  J. Cazenave,et al.  The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells , 1997, FEBS letters.

[309]  J. T. Turner,et al.  Transient up-regulation of P2Y2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[310]  J. Ballesteros,et al.  Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. , 2001, Molecular pharmacology.

[311]  Tobias Welte,et al.  ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[312]  B. Khakh,et al.  ATP Excites Interneurons and Astrocytes to Increase Synaptic Inhibition in Neuronal Networks , 2004, The Journal of Neuroscience.

[313]  J. Pfeilschifter,et al.  Heterologous desensitization of the sphingosine‐1‐phosphate receptors by purinoceptor activation in renal mesangial cells , 2004, British journal of pharmacology.

[314]  B B Fredholm,et al.  ATP and its metabolite adenosine act synergistically to mobilize intracellular calcium via the formation of inositol 1,4,5-trisphosphate in a smooth muscle cell line. , 1992, The Journal of biological chemistry.

[315]  T. K. Harden,et al.  Differential Regulation of the Uridine Nucleotide-activated P2Y4 and P2Y6 Receptors , 2001, The Journal of Biological Chemistry.

[316]  Wan-Wan Lin,et al.  PKC‐ and ERK‐dependent activation of IκB kinase by lipopolysaccharide in macrophages: enhancement by P2Y receptor‐mediated CaMK activation , 2001, British journal of pharmacology.

[317]  A. R. Lind,et al.  Identification of adenosine triphosphate in human plasma and the concentration in the venous effluent of forearm muscles before, during and after sustained contractions , 1969, The Journal of physiology.

[318]  W. Watt,et al.  UDP activates a mucosal-restricted receptor on human nasal epithelial cells that is distinct from the P2Y2 receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[319]  E. M. Jones,et al.  Cloning of rat and mouse P2Y purinoceptors. , 1995, Biochemical and biophysical research communications.

[320]  J. Furness,et al.  Characterisation of neurons expressing calbindin immunoreactivity in the ileum of the unweaned and mature sheep , 2004, Cell and Tissue Research.

[321]  A. Ewing,et al.  Amperometric monitoring of stimulated catecholamine release from rat pheochromocytoma (PC12) cells at the zeptomole level. , 1994, Analytical chemistry.

[322]  R. Evans,et al.  A study of P2X1 receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors , 2002, British journal of pharmacology.

[323]  G. Willars,et al.  Ca2+ signalling by recombinant human CXCR2 chemokine receptors is potentiated by P2Y nucleotide receptors in HEK cells , 2002, British journal of pharmacology.

[324]  Y. Okada,et al.  Swelling‐activated, cystic fibrosis transmembrane conductance regulator‐augmented ATP release and Cl− conductances in murine C127 cells , 2000, The Journal of physiology.

[325]  P. Ohlmann,et al.  The P2Y1 Receptor Is Normal in a Patient Presenting a Severe Deficiency of ADP-induced Platelet Aggregation , 1999, Thrombosis and Haemostasis.

[326]  C. Kuhn,et al.  UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors. , 2002, American journal of physiology. Heart and circulatory physiology.

[327]  Y. Smith,et al.  P2Y1 receptor signaling is controlled by interaction with the PDZ scaffold NHERF-2 , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[328]  E. Barnard,et al.  Identification of 6H1 as a P2Y purinoceptor: P2Y5. , 1996, Biochemical and biophysical research communications.

[329]  J. Goding,et al.  Plasma cell membrane glycoprotein PC-1. Primary structure deduced from cDNA clones. , 1987, The Journal of biological chemistry.

[330]  Patrick Delmas,et al.  Functional organization of PLC signaling microdomains in neurons , 2004, Trends in Neurosciences.

[331]  Jianguo Jin,et al.  Coordinated Signaling through Both G12/13 and Gi Pathways Is Sufficient to Activate GPIIb/IIIa in Human Platelets* , 2002, The Journal of Biological Chemistry.

[332]  C. Gachet,et al.  The P2 receptors in platelet function. , 2005, Seminars in thrombosis and hemostasis.

[333]  J. Pintor,et al.  Diadenosine polyphosphates, extracellular function and catabolism. , 1999, Progress in brain research.

[334]  K. Jacobson,et al.  Quantitation of the P2Y(1) receptor with a high affinity radiolabeled antagonist. , 2002, Molecular pharmacology.

[335]  E. Barnard,et al.  Cloning and chromosomal localization of the human P2Y1 purinoceptor. , 1996, Biochemical and biophysical research communications.

[336]  M. Kassack,et al.  Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists. , 2002, Current pharmaceutical design.

[337]  T. Steinberg,et al.  Cell to Cell Communication in Response to Mechanical Stress via Bilateral Release of Atp and Utp in Polarized Epithelia , 2000, The Journal of cell biology.

[338]  Jian Yang,et al.  Phosphotidylinositol 4,5-Bisphosphate Signals Underlie Receptor-Specific Gq/11-Mediated Modulation of N-Type Ca2+ Channels , 2004, The Journal of Neuroscience.

[339]  C. Müller P2-pyrimidinergic receptors and their ligands. , 2002, Current pharmaceutical design.

[340]  R. Unwin,et al.  Extended pharmacological profiles of rat P2Y2 and rat P2Y4 receptors and their sensitivity to extracellular H+ and Zn2+ ions , 2003, British journal of pharmacology.

[341]  M. Freund,et al.  Inhibition of localized thrombosis in P2Y1‐deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist , 2003, Journal of thrombosis and haemostasis : JTH.

[342]  A. Toker,et al.  The Lipid Products of Phosphoinositide 3-Kinase Contribute to Regulation of Cholangiocyte ATP and Chloride Transport* , 1999, The Journal of Biological Chemistry.

[343]  J. Ruppersberg,et al.  Regulation of GIRK channel deactivation by Gαq and Gαi/o pathways , 2000, Neuropharmacology.

[344]  B. Payrastre,et al.  A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. , 1999, Blood.

[345]  J. Boeynaems,et al.  Overview of P2Y receptors as therapeutic targets , 2001 .

[346]  Jinhai Gao,et al.  Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors , 2004, Nature.

[347]  G. Vassort Adenosine 5'-triphosphate: a P2-purinergic agonist in the myocardium. , 2001, Physiological reviews.

[348]  M. Taniguchi,et al.  Effect of YM-254890, a specific Galphaq/11 inhibitor, on experimental peripheral arterial disease in rats. , 2006, European journal of pharmacology.

[349]  E. Barnard,et al.  Molecular Cloning of a Novel P2 Purinoceptor from Human Erythroleukemia Cells* , 1996, The Journal of Biological Chemistry.

[350]  W. Watt,et al.  Enzymatic synthesis of UTPγS, a potent hydrolysis resistant agonist of P2U‐purinoceptors , 1996 .

[351]  Y. Agazie,et al.  ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. , 1998, American journal of physiology. Heart and circulatory physiology.

[352]  Graeme Milligan,et al.  G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology , 2004, Molecular Pharmacology.

[353]  K. Jacobson,et al.  Shift in purine/pyrimidine base recognition upon exchanging extracellular domains in P2Y 1/6 chimeric receptors. , 2004, Biochemical pharmacology.

[354]  J. E. Matos,et al.  K+ secretion activated by luminal P2Y2 and P2Y4 receptors in mouse colon , 2005, The Journal of physiology.

[355]  G. Burnstock,et al.  Localisation of P2Y1 and P2Y4 receptors in dorsal root, nodose and trigeminal ganglia of the rat , 2003, Histochemistry and Cell Biology.

[356]  Min Goo Lee,et al.  Membrane-specific expression of functional purinergic receptors in normal human nasal epithelial cells. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[357]  F. Di Virgilio,et al.  Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes. , 2002, Blood.

[358]  L. Bolis,et al.  Cell membrane receptors for drugs and hormones : a multidisciplinary approach , 1978 .

[359]  Takao Shimizu,et al.  A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis , 1997, Nature.

[360]  J. Debus,et al.  Detection and quantification of the soluble form of the human erythropoietin receptor (sEpoR) in the growth medium of tumor cell lines and in the plasma of blood samples , 2002, Clinical and Experimental Medicine.

[361]  M. Southey,et al.  Expression of the P2Y6 purinergic receptor in human T cells infiltrating inflammatory bowel disease. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[362]  G. Burnstock,et al.  Cellular distribution and functions of P2 receptor subtypes in different systems. , 2004, International review of cytology.

[363]  S. Soltoff Related Adhesion Focal Tyrosine Kinase and the Epidermal Growth Factor Receptor Mediate the Stimulation of Mitogen-activated Protein Kinase by the G-protein-coupled P2Y2 Receptor , 1998, The Journal of Biological Chemistry.

[364]  J. T. Turner,et al.  Mechanisms of agonist-dependent and -independent desensitization of a recombinant P2Y2 nucleotide receptor , 2000, Molecular and Cellular Biochemistry.

[365]  Y. Kanaoka,et al.  Cysteinyl Leukotrienes and Their Receptors: Cellular Distribution and Function in Immune and Inflammatory Responses1 , 2004, The Journal of Immunology.

[366]  J. T. Turner,et al.  Desensitization of P2Y2 receptor-activated transepithelial anion secretion. , 1999, The American journal of physiology.

[367]  K. Stenmark,et al.  Extracellular ATP Is an Autocrine/Paracrine Regulator of Hypoxia-induced Adventitial Fibroblast Growth , 2002, The Journal of Biological Chemistry.

[368]  J. Boeynaems,et al.  Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on human monocyte‐derived dendritic cells , 2004, Journal of leukocyte biology.

[369]  M. Boarder,et al.  P2Y Receptors: Structure and Function , 2001 .

[370]  G. M. Smith,et al.  Cloning and Characterization of a Bovine P2Y Receptor , 1995 .

[371]  J. Schrader,et al.  Cloning of the rat P2u receptor and its potential role in coronary vasodilation. , 1996, The American journal of physiology.

[372]  F. Bianco,et al.  Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia , 2005, Brain Research Reviews.

[373]  G. Burnstock,et al.  P2X and P2Y purinoceptor expression in pancreas from streptozotocin-diabetic rats , 2003, Molecular and Cellular Endocrinology.

[374]  D. Brown,et al.  Relationship between Membrane Phosphatidylinositol-4,5- Bisphosphate and Receptor-mediated Inhibition of Native Neuronal M Channels the Relationship between Receptor-induced Membrane Phosphatidylinositol-4ј5ј-bisphosphate (pip 2 ) Hydrolysis and M-current Inhi- Bition Was Assessed in Single-dissocia , 2022 .

[375]  J. Boeynaems,et al.  Nucleotide receptor P2Y4 , 2005 .

[376]  S. Soltoff,et al.  P2Y6 Nucleotide Receptor Mediates Monocyte Interleukin-8 Production in Response to UDP or Lipopolysaccharide* , 2001, The Journal of Biological Chemistry.

[377]  G. Burnstock,et al.  Abundant and dynamic expression of G protein‐coupled P2Y receptors in mammalian development , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.

[378]  G. Cristalli,et al.  Effects of 5'-phosphate derivatives of 2-hexynyl adenosine and 2-phenylethynyl adenosine on responses of human platelets mediated by P2Y receptors. , 2005, Journal of medicinal chemistry.

[379]  S. Kunapuli,et al.  Molecular mechanism of nucleotide-induced primary granule release in human neutrophils: role for the P2Y2 receptor. , 2004, American journal of physiology. Cell physiology.

[380]  K. Jacobson,et al.  Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors. , 1998, Journal of medicinal chemistry.

[381]  E. Barnard,et al.  Expression of the P2Y1 Nucleotide Receptor in Chick Muscle: Its Functional Role in the Regulation of Acetylcholinesterase and Acetylcholine Receptor , 2001, The Journal of Neuroscience.

[382]  J. Balsinde,et al.  Phospholipase A2 regulation of arachidonic acid mobilization , 2002, FEBS letters.

[383]  Bertil Hille,et al.  Modulation of ion-channel function by G-protein-coupled receptors , 1994, Trends in Neurosciences.

[384]  S. G. Lechner,et al.  Autoinhibition of transmitter release from PC12 cells and sympathetic neurons through a P2Y12 receptor‐mediated inhibition of voltage‐gated Ca2+ channels , 2004, The European journal of neuroscience.

[385]  K. Jacobson,et al.  Purine and pyrimidine (P2) receptors as drug targets. , 2002, Journal of medicinal chemistry.

[386]  M. Parmentier,et al.  Expression of P2Y receptors in cell lines derived from the human lung , 1999, British journal of pharmacology.

[387]  G. Burnstock,et al.  Early Expression of a Novel Nucleotide Receptor in the Neural Plate of Xenopus Embryos* , 1997, The Journal of Biological Chemistry.

[388]  G. Burnstock,et al.  Characterization of the Ca2+ responses evoked by ATP and other nucleotides in mammalian brain astrocytes , 1997, British journal of pharmacology.

[389]  J. T. Turner,et al.  Extracellular UTP stimulates electrogenic bicarbonate secretion across CFTR knockout gallbladder epithelium. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[390]  J. Foskett,et al.  CFTR Cl− channel and CFTR‐associated ATP channel: distinct pores regulated by common gates , 1998, The EMBO journal.

[391]  G. Burnstock,et al.  The Pattern of Distribution of Selected ATP-Sensitive P2 Receptor Subtypes in Normal Rat Kidney: An Immunohistological Study , 2003, Cells Tissues Organs.

[392]  J. Changeux,et al.  Targeting Transcription to the Neuromuscular Synapse , 2001, Neuron.

[393]  David Julius,et al.  ATP transduces signals from ASGM1, a glycolipid that functions as a bacterial receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[394]  J. Järv,et al.  Adenosine-derived non-phosphate antagonists for P2Y(1) purinoceptors. , 2000, Biochemical and biophysical research communications.

[395]  G. Burnstock,et al.  Cloning and functional expression of a brain G‐protein‐coupled ATP receptor , 1993, FEBS letters.

[396]  F. Sistare,et al.  Distribution of P2Y receptor subtypes on haematopoietic cells , 1998, British journal of pharmacology.

[397]  M. Matteoli,et al.  Nucleotide‐mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors , 2003, Glia.

[398]  J. Herbert,et al.  Identification and Biological Activity of the Active Metabolite of Clopidogrel , 2000, Thrombosis and Haemostasis.

[399]  J. Bourguignon,et al.  Novel antagonists acting at the P2Y(1) purinergic receptor: synthesis and conformational analysis using potentiometric and nuclear magnetic resonance titration techniques. , 2002, Journal of medicinal chemistry.

[400]  G. Burnstock Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction , 1999, Journal of anatomy.

[401]  D. Kellerman,et al.  Diquafosol tetrasodium: a novel dry eye therapy , 2004, Expert opinion on investigational drugs.

[402]  Mu-ming Poo,et al.  ATP Released by Astrocytes Mediates Glutamatergic Activity-Dependent Heterosynaptic Suppression , 2003, Neuron.

[403]  G. Burnstock,et al.  ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: A novel role for the P2Y2 receptor in bone remodeling , 2002, Journal of cellular biochemistry.

[404]  J. Jakubowski,et al.  Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity. , 2005, Seminars in thrombosis and hemostasis.

[405]  G. Weisman,et al.  The P2Y2 Nucleotide Receptor Mediates Vascular Cell Adhesion Molecule-1 Expression through Interaction with VEGF Receptor-2 (KDR/Flk-1)* , 2004, Journal of Biological Chemistry.

[406]  B. Kishore,et al.  Extracellular nucleotide signaling along the renal epithelium. , 2001, American journal of physiology. Renal physiology.

[407]  I. Sims,et al.  Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates. , 2001, Bioorganic & medicinal chemistry letters.

[408]  G. Burnstock,et al.  Purinergic receptors are part of a signaling system for keratinocyte proliferation, differentiation, and apoptosis in human fetal epidermis. , 2003, The Journal of investigative dermatology.

[409]  G. Burnstock Pathophysiology and Therapeutic Potential of Purinergic Signaling , 2006, Pharmacological Reviews.

[410]  R. A. Kaiser,et al.  Evidence supporting the Nucleotide Axis Hypothesis: ATP release and metabolism by coronary endothelium. , 2001, American journal of physiology. Heart and circulatory physiology.

[411]  B. Morris,et al.  Capacity for Purinergic Control of Renin Promoter via P2Y11 Receptor and cAMP Pathways , 2000, Hypertension.

[412]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[413]  K. Jacobson,et al.  Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists. , 1999, Journal of medicinal chemistry.

[414]  F. Virgilio,et al.  Defective P2Y purinergic receptor function: A possible novel mechanism for impaired glucose transport , 2003, Journal of cellular physiology.

[415]  E. Schwiebert,et al.  Phosphatidylinositol 3-Kinase Contributes to Cell Volume Regulation through Effects on ATP Release* , 1998, The Journal of Biological Chemistry.

[416]  M. Salter,et al.  A novel P2‐purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat , 1995, British journal of pharmacology.

[417]  M. Miras-Portugal,et al.  Ecto-enzymatic hydrolysis of diadenosine polyphosphates by cultured adrenomedullary vascular endothelial cells. , 1997, The American journal of physiology.

[418]  Y. Kuroda,et al.  Hetero‐oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains , 2002, FEBS letters.

[419]  K. Jacobson,et al.  Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptor. , 2004, Biochemical pharmacology.

[420]  Geoffrey Burnstock,et al.  Purinergic Signalling: ATP Release , 2001, Neurochemical Research.

[421]  S. Jalkanen,et al.  Extracellular ATP formation on vascular endothelial cells is mediated by ecto‐nucleotide kinase activities via phosphotransfer reactions , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[422]  S. Donaldson,et al.  Secreted and cell-associated adenylate kinase and nucleoside diphosphokinase contribute to extracellular nucleotide metabolism on human airway surfaces. , 2002, American journal of respiratory cell and molecular biology.

[423]  R. Olson,et al.  Release of ATP during host cell killing by enteropathogenic E. coli and its role as a secretory mediator. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[424]  G. Dubyak,et al.  Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. , 1999, American journal of physiology. Cell physiology.

[425]  T. K. Harden,et al.  Second messenger cascade specificity and pharmacological selectivity of the human P2Y1‐purinoceptor , 1996, British journal of pharmacology.

[426]  E. Barnard,et al.  Activation and inhibition of neuronal G protein-gated inwardly rectifying K(+) channels by P2Y nucleotide receptors. , 2004, Molecular pharmacology.

[427]  Andrew D. Powell,et al.  Identification of the P2Y12 Receptor in Nucleotide Inhibition of Exocytosis from Bovine Chromaffin Cells , 2004, Molecular Pharmacology.

[428]  H. Cantiello,et al.  The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel. , 1994, The Journal of biological chemistry.

[429]  B. Khakh,et al.  ATP Modulation of Excitatory Synapses onto Interneurons , 2003, The Journal of Neuroscience.

[430]  P. Conley,et al.  Novel Tricyclic Benzothiazolo[2,3-c]thiadiazine Antagonists of the Platelet ADP Receptor (P2Y12). , 2001 .

[431]  R. G. Humphries,et al.  Preclinical and Clinical Studies with Selective Reversible Direct P2Y12 Antagonists , 2005, Seminars in thrombosis and hemostasis.

[432]  H. Koike,et al.  Antiplatelet action of R‐99224, an active metabolite of a novel thienopyridine‐type Gi‐linked P2T antagonist, CS‐747 , 2001, British journal of pharmacology.

[433]  G. Burnstock,et al.  Purinoceptors: are there families of P2X and P2Y purinoceptors? , 1994, Pharmacology & therapeutics.

[434]  P. Emson,et al.  Cloning, pharmacology, and tissue distribution of G-protein-coupled receptor GPR105 (KIAA0001) rodent orthologs. , 2001, Genomics.

[435]  Nina L. Siow,et al.  ATP induces post-synaptic gene expressions in vertebrate skeletal neuromuscular junctions , 2003, Journal of neurocytology.

[436]  W. Watt,et al.  Pharmacological selectivity of the cloned human P2U‐purinoceptor: potent activation by diadenosine tetraphosphate , 1995, British journal of pharmacology.

[437]  D. Erlinge,et al.  P2 Receptor Expression Profiles in Human Vascular Smooth Muscle and Endothelial Cells , 2002, Journal of cardiovascular pharmacology.

[438]  A. Delgado-Escueta,et al.  Rat Brain Synaptosomal ATP:AMP‐Phosphotransferase Activity , 1989, Journal of neurochemistry.

[439]  E. Barnard,et al.  Dual coupling of heterologously‐expressed rat P2Y6 nucleotide receptors to N‐type Ca2+ and M‐type K+ currents in rat sympathetic neurones , 1999, British journal of pharmacology.

[440]  J. Bennett Novel platelet inhibitors. , 2001, Annual review of medicine.

[441]  S. Strömblad,et al.  p21-activated kinase 4 interacts with integrin αvβ5 and regulates αvβ5-mediated cell migration , 2002, The Journal of cell biology.

[442]  R. A. Kaiser,et al.  Nucleotide‐mediated relaxation in guinea‐pig aorta: selective inhibition by MRS2179 , 2002, British journal of pharmacology.

[443]  M. Accomazzo,et al.  CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation , 2005, Journal of Cell Science.

[444]  S. Kunapuli,et al.  Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[445]  J. Pearson,et al.  Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides , 1979, Nature.

[446]  B. Öztürk,et al.  Altered Relaxant Responses to Adenosine and Adenosine 5′-Triphosphate in the Corpus cavernosum from Men and Rats with Diabetes , 2000, Pharmacology.

[447]  B. Fredholm,et al.  Synergistic Effects of Adenosine A1 and P2Y Receptor Stimulation on Calcium Mobilization and PKC Translocation in DDT1 MF-2 Cells , 2003, Cellular and Molecular Neurobiology.

[448]  A. Muscella,et al.  Activation of P2Y2 receptor induces c‐FOS protein through a pathway involving mitogen‐activated protein kinases and phosphoinositide 3‐kinases in HeLa cells , 2003, Journal of cellular physiology.

[449]  T. K. Harden,et al.  The 6H1 orphan receptor, claimed to be the p2y5 receptor, does not mediate nucleotide-promoted second messenger responses. , 1997, Biochemical and biophysical research communications.

[450]  J. Pintor,et al.  Ca2+ Signalling in Brain Synaptosomes Activated by Dinucleotides , 2003, The Journal of Membrane Biology.

[451]  J. T. Turner,et al.  Desensitization of P2Y2receptor-activated transepithelial anion secretion. , 1999, American journal of physiology. Cell physiology.

[452]  S. Lohmann,et al.  cGMP Inhibition of Na+/H+ Antiporter 3 (NHE3) Requires PDZ Domain Adapter NHERF2, a Broad Specificity Protein Kinase G-anchoring Protein* , 2005, Journal of Biological Chemistry.

[453]  R. Arceci,et al.  The multidrug resistance (mdr1) gene product functions as an ATP channel. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[454]  K. Sano,et al.  Molecular cloning and chromosomal localization of PD-Ibeta (PDNP3), a new member of the human phosphodiesterase I genes. , 1997, Genomics.

[455]  E. Barnard,et al.  P2Y2 Nucleotide Receptors Expressed Heterologously in Sympathetic Neurons Inhibit Both N-Type Ca2+ and M-Type K+ Currents , 1998, The Journal of Neuroscience.

[456]  Herbert Zimmermann Signalling via ATP in the nervous system , 1994, Trends in Neurosciences.

[457]  X. Pillois,et al.  Nucleotide Receptors Involved in UTP-Induced Rat Arterial Smooth Muscle Cell Migration , 2002, Circulation research.

[458]  J. Boeynaems,et al.  Pharmacological characterization of the human P2Y13 receptor. , 2003, Molecular pharmacology.

[459]  M. Parmentier,et al.  Cloning and Functional Expression of a Human Uridine Nucleotide Receptor (*) , 1995, The Journal of Biological Chemistry.

[460]  R. Boucher,et al.  Human Airway Ecto-adenylate Kinase , 2003, The Journal of Biological Chemistry.

[461]  R. Evans,et al.  P2X(1) receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries. , 2002, Molecular pharmacology.

[462]  H. Slegers,et al.  P2Y12 receptor stimulation inhibits β‐adrenergic receptor‐induced differentiation by reversing the cyclic AMP‐dependent inhibition of protein kinase B , 2004, Journal of neurochemistry.

[463]  A. Methner,et al.  Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands , 2002, Genome Biology.

[464]  G. Burnstock,et al.  ATP is released from guinea pig ureter epithelium on distension. , 2002, American journal of physiology. Renal physiology.

[465]  G. Burnstock,et al.  Characterization of the signalling pathways involved in ATP and basic fibroblast growth factor‐induced astrogliosis , 1997, British journal of pharmacology.

[466]  L. Liotta,et al.  cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases. , 1994, The Journal of biological chemistry.

[467]  R. Boucher,et al.  Constitutive Release of ATP and Evidence for Major Contribution of Ecto-nucleotide Pyrophosphatase and Nucleoside Diphosphokinase to Extracellular Nucleotide Concentrations* , 2000, The Journal of Biological Chemistry.

[468]  Beverly H. Koller,et al.  Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice , 1999, Nature Medicine.

[469]  J. T. Turner,et al.  Site-directed Mutagenesis of P2U Purinoceptors , 1995, The Journal of Biological Chemistry.

[470]  Q. Zhu,et al.  Synergistic Activation of DNA Synthesis in Astrocytes by Fibroblast Growth Factors and Extracellular ATP , 1994, Journal of neurochemistry.

[471]  A. Bengtsson,et al.  P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells , 2004, BMC Immunology.

[472]  A. Reichenbach,et al.  P2 receptors in satellite glial cells in trigeminal ganglia of mice , 2003, Neuroscience.

[473]  B. Fredholm,et al.  Modulation of Hippocampal Glutamatergic Transmission by ATP Is Dependent on Adenosine A1 Receptors , 2002, Journal of Pharmacology and Experimental Therapeutics.

[474]  S. Ikeda Voltage-dependent modulation of N-type calcium channels by G-protein β γsubunits , 1996, Nature.

[475]  N. Ortéga,et al.  Extracellular matrix‐bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[476]  S. Pirotton,et al.  Pharmacological characterization of the human P2Y4 receptor. , 1996, European journal of pharmacology.

[477]  D. A. Brown,et al.  Inhibition by heterologously‐expressed P2Y2 nucleotide receptors of N‐type calcium currents in rat sympathetic neurones , 1997, British journal of pharmacology.

[478]  K. Baltensperger,et al.  The P2U Purinoceptor Obligatorily Engages the Heterotrimeric G Protein G16 to Mobilize Intracellular Ca2+ in Human Erythroleukemia Cells* , 1997, The Journal of Biological Chemistry.

[479]  H. Zimmermann,et al.  Extracellular purine metabolism , 1996 .

[480]  E. Jackson P1 and P2 Receptors in the Renal System , 2001 .

[481]  Takao Shimizu,et al.  Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family* , 2003, Journal of Biological Chemistry.

[482]  G. Burnstock,et al.  Characterisation of subtypes of the P2X and P2Y families of ATP receptors in the foetal human heart. , 1998, Life sciences.

[483]  J. T. Turner,et al.  Upregulation of P2Y2 nucleotide receptors in rat salivary gland cells during short-term culture. , 1997, The American journal of physiology.

[484]  H. Nakata,et al.  Hetero‐oligomerization between adenosine A1 and P2Y1 receptors in living cells: Formation of ATP‐sensitive adenosine receptors , 2003 .

[485]  E. Rowan,et al.  Crossing the Pain Barrier: P2 Receptors as Targets for Novel Analgesics , 2003, The Journal of physiology.

[486]  B. S. Brown,et al.  Modulation and genetic identification of the M channel. , 2000, Progress in biophysics and molecular biology.

[487]  V. Klepeis,et al.  P2Y receptors play a critical role in epithelial cell communication and migration , 2004, Journal of cellular biochemistry.

[488]  S. Moro,et al.  Evidence for the recognition of non‐nucleotide antagonists within the transmembrane domains of the human P2Y1 receptor , 2002, Drug development research.

[489]  P. Ohlmann,et al.  The P2Y1 receptor plays an essential role in the platelet shape change induced by collagen when TxA2 formation is prevented , 2004, Journal of thrombosis and haemostasis : JTH.

[490]  C. Gachet,et al.  The P2Y(1) receptor as a target for new antithrombotic drugs: a review of the P2Y(1) antagonist MRS-2179. , 2006, Cardiovascular drug reviews.

[491]  W. Catterall,et al.  Molecular Determinants for Modulation of Persistent Sodium Current by G-Protein βγ Subunits , 2005, The Journal of Neuroscience.

[492]  K. Patel,et al.  Selective expression of purinoceptor cP2Y1 suggests a role for nucleotide signalling in development of the chick embryo , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

[493]  K. Jacobson,et al.  Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation. , 2002, Journal of medicinal chemistry.

[494]  J. Neary,et al.  Mitogenic Signaling by ATP/P2Y Purinergic Receptors in Astrocytes: Involvement of a Calcium-Independent Protein Kinase C, Extracellular Signal-Regulated Protein Kinase Pathway Distinct from the Phosphatidylinositol-Specific Phospholipase C/Calcium Pathway , 1999, The Journal of Neuroscience.

[495]  L. Rochelle,et al.  Cloning and functional characterization of two murine uridine nucleotide receptors reveal a potential target for correcting ion transport deficiency in cystic fibrosis gallbladder. , 2001, The Journal of pharmacology and experimental therapeutics.

[496]  K. Jacobson,et al.  Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. , 2004, Journal of medicinal chemistry.

[497]  J. Cazenave,et al.  Adenine triphosphate nucleotides are antagonists at the P2Y12 receptor , 2004, Journal of thrombosis and haemostasis : JTH.

[498]  P. Nurden,et al.  An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function. , 1995, The Journal of clinical investigation.

[499]  G. Burnstock,et al.  Effect of shear stress on the release of soluble ecto‐enzymes ATPase and 5′‐nucleotidase along with endogenous ATP from vascular endothelial cells , 2000, British journal of pharmacology.

[500]  J. Inazawa,et al.  Molecular cloning and chromosomal assignment of the human brain-type phosphodiesterase I/nucleotide pyrophosphatase gene (PDNP2). , 1995, Genomics.

[501]  S. Moro,et al.  Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. , 1998, Journal of medicinal chemistry.

[502]  K. Baltensperger,et al.  Constitutive interaction of the P2Y2 receptor with the hematopoietic cell-specific G protein G(alpha16) and evidence for receptor oligomers. , 2005, Cellular signalling.

[503]  P. Illés,et al.  Stimulation of P2Y1 Receptors Causes Anxiolytic-like Effects in the Rat Elevated Plus-maze: Implications for the Involvement of P2Y1 Receptor-Mediated Nitric Oxide Production , 2003, Neuropsychopharmacology.

[504]  R. Nicholas,et al.  ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor. , 2000, Molecular pharmacology.

[505]  P. Insel,et al.  Inhibition of Phospholipase A2-mediated Arachidonic Acid Release by Cyclic AMP Defines a Negative Feedback Loop for P2Y Receptor Activation in Madin-Darby Canine Kidney D1 Cells* , 1999, The Journal of Biological Chemistry.

[506]  Colin A. Brown,et al.  Evaluation of reactive blue 2 derivatives as selective antagonists for P2Y receptors. , 2002, Vascular pharmacology.

[507]  G. Burnstock,et al.  Synergistic effect of acute hypoxia on flow-induced release of ATP from cultured endothelial cells , 1995, Experientia.

[508]  R. Boucher,et al.  Release of cellular UDP-glucose as a potential extracellular signaling molecule. , 2003, Molecular pharmacology.

[509]  D. Kellerman,et al.  Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung disease. , 2002, Advanced drug delivery reviews.

[510]  E. Barnard,et al.  The P2Y1 receptor closes the N‐type Ca2+ channel in neurones, with both adenosine triphosphates and diphosphates as potent agonists , 2000, British journal of pharmacology.

[511]  R. Bobbin,et al.  Localization of the P2Y4 receptor in the guinea pig organ of Corti. , 2003, Journal of the American Academy of Audiology.

[512]  A. Platt,et al.  Human Immature Monocyte-Derived Dendritic Cells Express the G Protein-Coupled Receptor GPR105 (KIAA0001, P2Y14) and Increase Intracellular Calcium in Response to its Agonist, Uridine Diphosphoglucose , 2003, The Journal of Immunology.

[513]  G. Weisman,et al.  Mechanisms by which extracellular ATP and UTP stimulate the release of prostacyclin from bovine pulmonary artery endothelial cells. , 1992, Biochimica et biophysica acta.

[514]  J. Cazenave,et al.  Desensitization of the Platelet Aggregation Response to ADP: Differential Down-regulation of the P2Y1 and P2cyc Receptors , 2000, Thrombosis and Haemostasis.

[515]  G. Willars,et al.  Cross Talk between P2Y2 Nucleotide Receptors and CXC Chemokine Receptor 2 Resulting in Enhanced Ca2+ Signaling Involves Enhancement of Phospholipase C Activity and Is Enabled by Incremental Ca2+ Release in Human Embryonic Kidney Cells , 2003, Journal of Pharmacology and Experimental Therapeutics.

[516]  D. Surmeier,et al.  D1/D5 Dopamine Receptor Activation Differentially Modulates Rapidly Inactivating and Persistent Sodium Currents in Prefrontal Cortex Pyramidal Neurons , 2001, The Journal of Neuroscience.

[517]  P. Illés,et al.  Inhibition of N-Type Voltage-Activated Calcium Channels in Rat Dorsal Root Ganglion Neurons by P2Y Receptors Is a Possible Mechanism of ADP-Induced Analgesia , 2004, The Journal of Neuroscience.

[518]  G. Burnstock,et al.  P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFalpha and potential role in myocardial cell death. , 2005, Journal of molecular and cellular cardiology.

[519]  D. Erlinge,et al.  Cytokines Induce Upregulation of Vascular P2Y2 Receptors and Increased Mitogenic Responses to UTP and ATP , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[520]  G. Burnstock,et al.  Cyclo‐oxygenase‐2 mediates P2Y receptor‐induced reactive astrogliosis , 1999, British journal of pharmacology.

[521]  P. Insel,et al.  P2Y(2) receptor of MDCK cells: cloning, expression, and cell-specific signaling. , 2000, American journal of physiology. Renal physiology.

[522]  M. Simon,et al.  G13 is an essential mediator of platelet activation in hemostasis and thrombosis , 2003, Nature Medicine.

[523]  T. D. Nguyen,et al.  P2Y(11), a purinergic receptor acting via cAMP, mediates secretion by pancreatic duct epithelial cells. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[524]  K. Bost,et al.  Extracellular uridine nucleotides initiate cytokine production by murine dendritic cells. , 1999, Cellular immunology.

[525]  J P Cazenave,et al.  Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. , 1999, The Journal of clinical investigation.

[526]  R. Bruzzone,et al.  Connexin-dependent inter-cellular communication increases invasion and dissemination of Shigella in epithelial cells , 2003, Nature Cell Biology.

[527]  G. Gorodeski Regulation of transcervical permeability by two distinct P2 purinergic receptor mechanisms. , 2002, American journal of physiology. Cell physiology.

[528]  M. Bollen,et al.  An Ecto‐Nucleotide Pyrophosphatase Is One of the Main Enzymes Involved in the Extracellular Metabolism of ATP in Rat C6 Glioma , 1999, Journal of neurochemistry.

[529]  A. Conigrave,et al.  Expression of the human P2Y6 nucleotide receptor in normal placenta and gestational trophoblastic disease. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[530]  K. Jacobson,et al.  CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors. , 2005, Biochemical pharmacology.

[531]  J. T. Turner,et al.  Structure and function of P2Y2 nucleotide receptors in cystic fibrosis (CF) epithelium. , 1997, Advances in experimental medicine and biology.

[532]  B. Nieswandt,et al.  The P2Y12 receptor induces platelet aggregation through weak activation of the αIIbβ3 integrin – a phosphoinositide 3‐kinase‐dependent mechanism , 2001 .

[533]  T. K. Harden,et al.  GPR80/99, proposed to be the P2Y15 receptor activated by adenosine and AMP, is not a P2Y receptor , 2004, Purinergic Signalling.

[534]  D. C. Marcus,et al.  Apical P2Y4 purinergic receptor controls K+ secretion by vestibular dark cell epithelium. , 2001, American journal of physiology. Cell physiology.

[535]  S. M. Sims,et al.  P2Y6 Nucleotide Receptors Activate NF-κB and Increase Survival of Osteoclasts* , 2005, Journal of Biological Chemistry.

[536]  J. Grosche,et al.  P2Y receptor expression on astrocytes in the nucleus accumbens of rats , 2004, Neuroscience.

[537]  F. Monsma,et al.  P2Y13: Identification and characterization of a novel Gαi-coupled ADP receptor from human and mouse , 2002 .

[538]  C. Bruyns,et al.  The P2Y11 Receptor Mediates the ATP-Induced Maturation of Human Monocyte-Derived Dendritic Cells1 , 2001, The Journal of Immunology.

[539]  M. Harmsen,et al.  Expression of P2 receptors at sites of chronic inflammation , 2004, Cell and Tissue Research.

[540]  P. Stanfield,et al.  Constitutively active and G-protein coupled inward rectifier K+ channels: Kir2.0 and Kir3.0. , 2002, Reviews of physiology, biochemistry and pharmacology.

[541]  T. K. Harden,et al.  Identification of competitive antagonists of the P2Y1 receptor. , 1996, Molecular pharmacology.

[542]  S. Palea,et al.  Evidence for purinergic neurotransmission in human urinary bladder affected by interstitial cystitis. , 1993, The Journal of urology.

[543]  K. Jacobson,et al.  Induction of Novel Agonist Selectivity for the ADP-Activated P2Y1 Receptor Versus the ADP-Activated P2Y12 and P2Y13 Receptors by Conformational Constraint of an ADP Analog , 2004, Journal of Pharmacology and Experimental Therapeutics.

[544]  F. Monsma,et al.  ADP Is the Cognate Ligand for the Orphan G Protein-coupled Receptor SP1999* , 2001, The Journal of Biological Chemistry.

[545]  E. Barnard,et al.  An elusive receptor is finally caught: P2Y(12'), an important drug target in platelets. , 2001, Trends in pharmacological sciences.

[546]  C. Gachet The platelet P2 receptors as molecular targets for old and new antiplatelet drugs. , 2005, Pharmacology & therapeutics.

[547]  M. Parmentier,et al.  Cloning, functional expression and tissue distribution of the human P2Y6 receptor. , 1996, Biochemical and biophysical research communications.

[548]  S. Moro,et al.  Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands. , 2000, Journal of medicinal chemistry.

[549]  Kyong-Tai Kim,et al.  G protein-coupled receptor signalling and cross-talk: achieving rapidity and specificity. , 2002, Cellular signalling.

[550]  Jilly F. Evans,et al.  Discovery and mapping of ten novel G protein-coupled receptor genes. , 2001, Gene.

[551]  P. Zaphiropoulos,et al.  Intergenic mRNAs. Minor gene products or tools of diversity? , 2002, Histology and histopathology.

[552]  J. Herbert,et al.  P2Y receptor antagonists in thrombosis. , 2005, Current opinion in investigational drugs.

[553]  W. Olijve,et al.  Molecular cloning and characterization of a novel orphan receptor (P2P) expressed in human pancreas that shows high structural homology to the P2U purinoceptor , 1996, FEBS letters.

[554]  K. Jacobson,et al.  Stimulation of Xenopus P2Y1 receptor activates CFTR in A6 cells , 2004, Pflügers Archiv.

[555]  V. Trinkaus-Randall,et al.  Modulation of endothelial cell migration by extracellular nucleotides , 2005, Thrombosis and Haemostasis.

[556]  M. Oike,et al.  Involvement of Rho‐kinase and tyrosine kinase in hypotonic stress‐induced ATP release in bovine aortic endothelial cells , 2001, The Journal of physiology.

[557]  W. Rice,et al.  Cloning and expression of the alveolar type II cell P2u-purinergic receptor. , 1995, American journal of respiratory cell and molecular biology.

[558]  G. Makhlouf,et al.  Coexpression of Ligand-gated P2X and G Protein-coupled P2Y Receptors in Smooth Muscle , 1998, The Journal of Biological Chemistry.

[559]  K. Jacobson,et al.  Identification of potent P2Y‐purinoceptor agonists that are derivatives of adenosine 5′‐monophosphate , 1996, British journal of pharmacology.

[560]  W. Watt,et al.  Cystic Fibrosis Transmembrane Regulator-independent Release of ATP , 1998, The Journal of Biological Chemistry.

[561]  F. Lottspeich,et al.  Affinity Purification and cDNA Cloning of Rat Neural Differentiation and Tumor Cell Surface Antigen gp130RB13-6 Reveals Relationship to Human and Murine PC-1 (*) , 1995, The Journal of Biological Chemistry.

[562]  E. Barnard,et al.  The P2Y Nucleotide Receptors in the Human Genome , 2003, Acta biologica Hungarica.

[563]  K. Sano,et al.  Hydrolysis of diadenosine polyphosphates by nucleotide pyrophosphatases/phosphodiesterases. , 2003, European journal of biochemistry.

[564]  Amal K. Dutta,et al.  Volume-Dependent Atp-Conductive Large-Conductance Anion Channel as a Pathway for Swelling-Induced Atp Release , 2001, The Journal of general physiology.

[565]  M. Parmentier,et al.  Identification of a Novel Human ADP Receptor Coupled to Gi * , 2001, The Journal of Biological Chemistry.

[566]  C. Gachet,et al.  Differential Involvement of the P2Y1 and P2YT Receptors in the Morphological Changes of Platelet Aggregation , 2001, Thrombosis and Haemostasis.

[567]  Kazuhide Inoue,et al.  Direct Excitation of Inhibitory Interneurons by Extracellular ATP Mediated by P2Y1 Receptors in the Hippocampal Slice , 2004, The Journal of Neuroscience.

[568]  R. Sabirov,et al.  ATP-conducting maxi-anion channel: a new player in stress-sensory transduction. , 2004, The Japanese journal of physiology.

[569]  K. Jacobson,et al.  Competitive and selective antagonism of P2Y1 receptors by N6‐methyl 2′‐deoxyadenosine 3′,5′‐bisphosphate , 1998, British journal of pharmacology.

[570]  E. Barnard,et al.  Activity of adenosine diphosphates and triphosphates on a P2YT‐type receptor in brain capillary endothelial cells , 2001, British journal of pharmacology.

[571]  K. Jacobson,et al.  2‐Chloro N6‐methyl‐(N)‐methanocarba‐2′‐deoxyadenosine‐3′,5′‐bisphosphate is a selective high affinity P2Y1 receptor antagonist , 2002 .

[572]  Richard C Boucher,et al.  Metabolism of P2 Receptor Agonists in Human Airways , 2004, Journal of Biological Chemistry.

[573]  Haslam Rj Interactions of the pharmacological receptors of blood platelets with adenylate cyclase. , 1973 .

[574]  P. Conley,et al.  Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis , 2003, Current opinion in hematology.

[575]  L. Cantley,et al.  Activation of P2Y2 Receptors by UTP and ATP Stimulates Mitogen-activated Kinase Activity through a Pathway That Involves Related Adhesion Focal Tyrosine Kinase and Protein Kinase C* , 1998, The Journal of Biological Chemistry.

[576]  J. Lüthje,et al.  Catabolism of Ap4A and Ap3A in whole blood. The dinucleotides are long-lived signal molecules in the blood ending up as intracellular ATP in the erythrocytes. , 1988, European journal of biochemistry.

[577]  M. Masu,et al.  Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[578]  M. Freund,et al.  Key Role of the P2Y1 Receptor in Tissue Factor–Induced Thrombin-Dependent Acute Thromboembolism: Studies in P2Y1-Knockout Mice and Mice Treated With a P2Y1 Antagonist , 2001 .

[579]  M. Donowitz,et al.  NHERF family and NHE3 regulation , 2005, The Journal of physiology.

[580]  G. Reiser,et al.  Fluorescent epsilon-ATP analogues for probing physicochemical properties of proteins. Synthesis, biochemical evaluation, and sensitivity to properties of the medium. , 2004, Bioorganic & medicinal chemistry.

[581]  J. Cazenave,et al.  Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor. , 1996, Gene.

[582]  J. Boeynaems,et al.  Molecular cloning and characterization of the mouse P2Y4 nucleotide receptor. , 2001, European journal of pharmacology.

[583]  F. Sinigaglia,et al.  A Gi-dependent Pathway Is Required for Activation of the Small GTPase Rap1B in Human Platelets* , 2002, The Journal of Biological Chemistry.

[584]  J. Grosche,et al.  P2X receptor expression on astrocytes in the nucleus accumbens of rats , 2001, Neuroscience.

[585]  G. Bernardi,et al.  Effect of P2 purinoceptor antagonists on kainate-induced currents in rat cultured neurons , 2000, Brain Research.

[586]  V. Rakyan,et al.  Extracellular ATP couples to cAMP generation and granulocytic differentiation in human NB4 promyelocytic leukaemia cells , 2000, Immunology and cell biology.

[587]  G. Dubyak,et al.  Colocalization of ATP Release Sites and Ecto-ATPase Activity at the Extracellular Surface of Human Astrocytes* , 2003, Journal of Biological Chemistry.

[588]  Chih‐Chung Lin,et al.  P2Y2 receptor‐mediated proliferation of C6 glioma cells via activation of Ras/Raf/MEK/MAPK pathway , 2000, British journal of pharmacology.

[589]  R. Boucher,et al.  Biochemical evidence for an ecto alkaline phosphodiesterase I in human airways. , 2000, American journal of respiratory cell and molecular biology.

[590]  P. White,et al.  Characterization of a Ca2+ response to both UTP and ATP at human P2Y11 receptors: evidence for agonist-specific signaling. , 2003, Molecular pharmacology.

[591]  Amal K. Dutta,et al.  Regulation of an ATP‐conductive large‐conductance anion channel and swelling‐induced ATP release by arachidonic acid , 2002, The Journal of physiology.

[592]  K. Honn,et al.  Overexpression of Platelet-type 12-Lipoxygenase Promotes Tumor Cell Survival by Enhancing v 3 and v 5 Integrin Expression 1 , 2003 .

[593]  T. Gudermann,et al.  A novel subgroup of class I G-protein-coupled receptors. , 1999, Biochimica et biophysica acta.

[594]  Tzu-Ling Cheng,et al.  An ecdysone and tetracycline dual regulatory expression system for studies on Rac1 small GTPase-mediated signaling. , 2003, American journal of physiology. Cell physiology.

[595]  P. Emson,et al.  Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimer's disease , 2000, Neuroreport.

[596]  K. Fukuzawa,et al.  Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase* , 2002, The Journal of Biological Chemistry.

[597]  Shumei Yang,et al.  Purinergic axis in cardiac blood vessels. Agonist-mediated release of ATP from cardiac endothelial cells. , 1994, Circulation research.

[598]  R. Boucher,et al.  Interplay of constitutively released nucleotides, nucleotide metabolism, and activity of P2Y receptors , 2001 .

[599]  J. Herbert,et al.  FcγRIIA requires a Gi-dependent pathway for an efficient stimulation of phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation , 2000 .

[600]  D. Haber,et al.  P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bone-marrow hematopoietic stem cells. , 2003, Genes & development.

[601]  J. Neary,et al.  Activation of Extracellular Signal-Regulated Kinase by Stretch-Induced Injury in Astrocytes Involves Extracellular ATP and P2 Purinergic Receptors , 2003, The Journal of Neuroscience.

[602]  Amal K. Dutta,et al.  Detecting ATP Release by a Biosensor Method , 2004, Science's STKE.

[603]  G. Sharpe,et al.  Human keratinocytes express multiple P2Y-receptors: evidence for functional P2Y1, P2Y2, and P2Y4 receptors. , 2003, The Journal of investigative dermatology.

[604]  H. Schiöth,et al.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.

[605]  B. Ozturk,et al.  Altered relaxant responses to adenosine and adenosine 5'-triphosphate in the corpus cavernosum from men and rats with diabetes. , 2000 .

[606]  T. Nakagawa,et al.  Analgesic Effects of Intrathecal Administration of P2Y Nucleotide Receptor Agonists UTP and UDP in Normal and Neuropathic Pain Model Rats , 2002, Journal of Pharmacology and Experimental Therapeutics.

[607]  L. Garrett-Sinha,et al.  The Ets Factors PU.1 and Spi-B Regulate the Transcriptionin Vivo of P2Y10, a Lymphoid Restricted Heptahelical Receptor* , 1999, The Journal of Biological Chemistry.

[608]  E. Schwiebert,et al.  Extracellular ATP signaling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells. , 2002, American journal of physiology. Cell physiology.

[609]  C. Gachet ADP Receptors of Platelets and their Inhibition , 2001, Thrombosis and Haemostasis.

[610]  P. D. Bell,et al.  Macula densa cell signaling. , 2003, Annual review of physiology.

[611]  M. Freund,et al.  Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist. , 2001, Circulation.

[612]  T Kendall Harden,et al.  Nucleotide analogues containing 2-oxa-bicyclo[2.2.1]heptane and l-alpha-threofuranosyl ring systems: interactions with P2Y receptors. , 2004, Bioorganic & medicinal chemistry.

[613]  J. Bourguignon,et al.  Synthesis and biological activity of 2-alkylated deoxyadenosine bisphosphate derivatives as P2Y(1) receptor antagonists. , 2004, Bioorganic & medicinal chemistry.

[614]  T. K. Harden,et al.  A molecularly identified P2Y receptor simultaneously activates phospholipase C and inhibits adenylyl cyclase and is nonselectively activated by all nucleoside triphosphates. , 2000, Molecular pharmacology.

[615]  P. Illés,et al.  P2 receptor‐mediated proliferative effects on astrocytes in vivo , 1999, Glia.